399 results
Page 3 of 20
8-K
EX-99.1
gnwglp1dl64bo bh
14 Nov 22
Windtree Therapeutics Reports Third Quarter 2022 Financial Results and Provides Key Business Updates
7:33am
8-K
EX-99.1
7sf54zkhagy99s1w
23 Aug 22
Windtree Therapeutics Announces KL4 Surfactant and AEROSURF® Global License Agreement
8:30am
8-K
EX-99.1
3n80km8xv xmrvovay
11 Aug 22
Windtree Therapeutics Reports Second Quarter 2022 Financial Results and Provides Key Business Updates
4:06pm
DEFA14A
51v xdzh0
3 Jun 22
Additional proxy soliciting materials
4:05pm
8-K
EX-99.1
90hal8fbligu2qy5g3
23 May 22
The study met its primary endpoint of improved systolic blood pressure (SBP) profile at 6 hours
4:01pm
8-K
EX-99.1
pg1c9ir5bite4sf
5 May 22
Windtree Therapeutics Reports First Quarter 2022 Financial Results and Provides Key Business Updates
4:04pm
8-K
EX-99.1
th9x 3ze09j55ltn8nd
20 Apr 22
Windtree Announces Positive Topline Results from Its
7:07am
8-K
EX-99.1
17k1109y
31 Mar 22
Windtree Therapeutics Reports Fourth Quarter and Year-End 2021 Financial Results and Provides Key Business Updates
7:05am
8-K
EX-99.1
5zrffnivah
15 Mar 22
Windtree Completes Enrollment of Phase 2 Study of Istaroxime in Early Cardiogenic Shock
7:04am
8-K
EX-99.1
zysp67me6h2hxi
10 Nov 21
Windtree Therapeutics Reports Third Quarter 2021 Financial Results and Provides Key Business Updates
4:05pm